Cambrex Corporation

(CBM) Trade

By |

Profile

Cambrex is a biotechnology company focused on developing and commercializing new and generic therapeutics. The company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. Cambrex's portfolio growth strategy has a particular focus on the later stages of the clinical trial process. It also works to secure long-term supply agreements to produce active pharmaceutical ingredients and intermediates for newly approved drug products. Additionally, Cambrex sometimes works with partners to codevelop portfolios of niche generic drug products in finished dosage form.

Contact Information

Website: www.cambrex.com
Email: stephanie.lafiura@cambrex.com
Main Phone: +1 201 804-3000
Address: One Meadowlands Plaza
Address 2: Suite 1400
State: NJ
City / Town: East Rutherford
Country: USA
Postal Code: 07073

Issuer Information

Exchange: NYE
CEO: Steven M. Klosk
Employees: 1228
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 45.27 $ -1.41 (-3.02%)
Last Price 45.27 Change $ -1.41 Change % -3.02 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 46.58 High 47.06 Low 45.05 Prev Close 46.68
Last Trade Volume 227,615 52 Wk Hi 69.43 52 Wk Low 44.93
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 33,560,061.00 EPS (TTM) 3.91 PE Ratio 11.60 Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 20 35
Number of Buys 14 23
Number of Sells 6 12
Net Activity 9779 30700
Last 10 Buys Shares
Louis J. Grabowsky 1,000
James Francis Winschel 1,000
Ilan Kaufthal 1,000
Ilan Kaufthal 1,000
Ilan Kaufthal 1,000
Rosina B. Dixon 1,000
Rosina B. Dixon 1,000
Ilan Kaufthal 1,000
Last 10 Sell Shares
Steven M. Klosk 1,000
Gregory P. Sargen 1,000
Gregory P. Sargen 1,000
Shawn Cavanagh 1,000
Gregory P. Sargen 1,000
Shawn Cavanagh 1,000
Steven M. Klosk 1,000
Steven M. Klosk 1,000
Steven M. Klosk 1,000
Steven M. Klosk 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 61 61 61 61
Low Target Price Estimate 60 60 60 60
Mean Target Price Estimate 60.5 60.5 60.5 60.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 06/04/18 02/28/18 02/28/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.4 1.4 1.4